日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cytopenias and infections following ciltacabtagene autoleucel in heavily pretreated relapsed or refractory multiple myeloma

在接受过大量预处理的复发或难治性多发性骨髓瘤患者中,使用ciltacabtagene autoleucel治疗后出现细胞减少症和感染

Dima, Danai; Logue, Jennifer M; Waqar, Syed Hamza Bin; Peres, Lauren C; Colin-Leitzinger, Christelle M; De Avila, Gabriel; Smith, Eric C; Skelson, Lawrence; Matte, Kristy L; Blue, Brandon; Hovanky, Vanna N; Gaballa, Mahmoud; Pasvolsky, Oren; Oswald, Laura B; Fortuna, Gliceida Galarza M; Wagner, Charlotte B; DeJarnette, Shaun; Dillard, Christen; Perna, Fabiana; Mikkilineni, Lekha; Hosoya, Hitomi; Freeman, Ciara L; Shain, Kenneth H; Baz, Rachid C; Grajales-Cruz, Ariel; Puglianini, Omar Castaneda; Alsina, Melissa; Locke, Frederick L; Shune, Leyla O; Sborov, Douglas W; Patel, Krina K; Sidana, Surbhi; Hansen, Doris K

Bayesian multi-cell type models for the analysis of complex immune cell populations with application to ovarian cancer

贝叶斯多细胞类型模型在复杂免疫细胞群分析中的应用及其在卵巢癌中的应用

Sakitis, Chase J; Laborde, Jose; Wrobel, Julia; Soupir, Alex C; Colin-Leitzinger, Christelle M; Bitler, Benjamin G; Townsend, Mary K; Lawson, Andrew B; Schildkraut, Joellen M; Tworoger, Shelley S; Terry, Kathryn L; Peres, Lauren C; Fridley, Brooke L

SHP2 inhibition displays efficacy as a monotherapy and in combination with JAK2 inhibition in preclinical models of myeloproliferative neoplasms.

在骨髓增生性肿瘤的临床前模型中,SHP2 抑制剂作为单一疗法以及与 JAK2 抑制剂联合使用均显示出疗效

Pandey Garima, Mazzacurati Lucia, Rowsell Tegan M, Horvat Nathan P, Amin Narmin E, Zhang Guolin, Akuffo Afua A, Colin-Leitzinger Christelle M, Haura Eric B, Kuykendall Andrew T, Zhang Ling, Epling-Burnette Pearlie K, Reuther Gary W

Impact of obesity on chemotherapy dosing of carboplatin and survival of women with ovarian cancer

肥胖对卵巢癌患者卡铂化疗剂量和生存率的影响

Martin, Alexandra L; Colin-Leitzinger, Christelle M; Sinha, Sweta K; Chern, Jing-Yi; Peres, Lauren C

Early cytopenias and infections after standard of care idecabtagene vicleucel in relapsed or refractory multiple myeloma

复发或难治性多发性骨髓瘤患者接受标准治疗方案idecabtagene vicleucel后出现早期血细胞减少和感染

Logue, Jennifer M; Peres, Lauren C; Hashmi, Hamza; Colin-Leitzinger, Christelle M; Shrewsbury, Alexandria M; Hosoya, Hitomi; Gonzalez, Rebecca M; Copponex, Christina; Kottra, Krista H; Hovanky, Vanna; Sahaf, Bita; Patil, Sunita; Lazaryan, Aleksandr; Jain, Michael D; Baluch, Aliyah; Klinkova, Olga V; Bejanyan, Nelli; Faramand, Rawan G; Elmariah, Hany; Khimani, Farhad; Davila, Marco L; Mishra, Asmita; Blue, Brandon J; Grajales-Cruz, Ariel F; Castaneda Puglianini, Omar A; Liu, Hien D; Nishihori, Taiga; Freeman, Ciara L; Brayer, Jason B; Shain, Kenneth H; Baz, Rachid C; Locke, Frederick L; Alsina, Melissa; Sidana, Surbhi; Hansen, Doris K

Racial and ethnic differences in clonal hematopoiesis, tumor markers, and outcomes of patients with multiple myeloma

多发性骨髓瘤患者克隆性造血、肿瘤标志物和预后的种族和民族差异

Peres, Lauren C; Colin-Leitzinger, Christelle M; Teng, Mingxiang; Dutil, Julie; Alugubelli, Raghunandan R; DeAvila, Gabriel; Teer, Jamie K; Du, Dongliang; Mo, Qianxing; Siegel, Erin M; Hampton, Oliver A; Alsina, Melissa; Brayer, Jason; Blue, Brandon; Baz, Rachid; Silva, Ariosto S; Nishihori, Taiga; Shain, Kenneth H; Gillis, Nancy

spatialTIME and iTIME: R package and Shiny application for visualization and analysis of immunofluorescence data

spatialTIME 和 iTIME:用于免疫荧光数据可视化和分析的 R 包和 Shiny 应用程序

Creed, Jordan H; Wilson, Christopher M; Soupir, Alex C; Colin-Leitzinger, Christelle M; Kimmel, Gregory J; Ospina, Oscar E; Chakiryan, Nicholas H; Markowitz, Joseph; Peres, Lauren C; Coghill, Anna; Fridley, Brooke L